$11.54
0.08[0.70%]
Last update: 3:09PM Get Real Time Here
Evolus Stock (NASDAQ:EOLS), Analyst Ratings, Price Targets, Predictions
Evolus Inc has a consensus price target of $19.89, established from looking at the 29 latest analyst ratings. The last 3 analyst ratings were released from Needham, Stifel, and Mizuho on April 10, 2024, March 8, 2024, and March 8, 2024. With an average price target of $23.33 between Needham, Stifel, and Mizuho, there's an implied 102.20% upside for Evolus Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Stifel
Mizuho
HC Wainwright & Co.
Barclays
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Evolus
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | EOLS | Buy Now | Evolus | $11.54 | 90.64% | Needham | Serge Belanger | → $22 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | EOLS | Buy Now | Evolus | $11.54 | 116.64% | Stifel | Annabel Samimy | $23 → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | EOLS | Buy Now | Evolus | $11.54 | 99.31% | Mizuho | Uy Ear | $20 → $23 | Maintains | Buy | Get Alert |
| 03/08/2024 | EOLS | Buy Now | Evolus | $11.54 | 90.64% | Needham | Serge Belanger | → $22 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | EOLS | Buy Now | Evolus | $11.54 | 133.97% | HC Wainwright & Co. | Douglas Tsao | → $27 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | EOLS | Buy Now | Evolus | $11.54 | 133.97% | HC Wainwright & Co. | Douglas Tsao | → $27 | Reiterates | Buy → Buy | Get Alert |
| 01/29/2024 | EOLS | Buy Now | Evolus | $11.54 | 38.65% | Barclays | Balaji Prasad | $10 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/17/2024 | EOLS | Buy Now | Evolus | $11.54 | 133.97% | HC Wainwright & Co. | Douglas Tsao | → $27 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | EOLS | Buy Now | Evolus | $11.54 | 90.64% | Needham | Serge Belanger | → $22 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | EOLS | Buy Now | Evolus | $11.54 | 133.97% | HC Wainwright & Co. | Douglas Tsao | $16 → $27 | Maintains | Buy | Get Alert |
| 08/03/2023 | EOLS | Buy Now | Evolus | $11.54 | 90.64% | Needham | Serge Belanger | → $22 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | EOLS | Buy Now | Evolus | $11.54 | 38.65% | HC Wainwright & Co. | Douglas Tsao | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | EOLS | Buy Now | Evolus | $11.54 | 73.31% | Mizuho | Uy Ear | $17 → $20 | Maintains | Buy | Get Alert |
| 05/26/2023 | EOLS | Buy Now | Evolus | $11.54 | 55.98% | Truist Securities | Gregory Fraser | $14 → $18 | Maintains | Buy | Get Alert |
| 05/10/2023 | EOLS | Buy Now | Evolus | $11.54 | 90.64% | Needham | Serge Belanger | $18 → $22 | Maintains | Buy | Get Alert |
| 05/10/2023 | EOLS | Buy Now | Evolus | $11.54 | 38.65% | HC Wainwright & Co. | Douglas Tsao | $15 → $16 | Maintains | Buy | Get Alert |
| 03/09/2023 | EOLS | Buy Now | Evolus | $11.54 | 55.98% | Needham | Serge Belanger | → $18 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | EOLS | Buy Now | Evolus | $11.54 | 29.98% | HC Wainwright & Co. | Douglas Tsao | → $15 | Reiterates | → Buy | Get Alert |
| 02/13/2023 | EOLS | Buy Now | Evolus | $11.54 | 55.98% | Needham | Serge Belanger | → $18 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Evolus (EOLS)?
The latest price target for Evolus (NASDAQ: EOLS) was reported by Needham on April 10, 2024. The analyst firm set a price target for $22.00 expecting EOLS to rise to within 12 months (a possible 90.64% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evolus (EOLS)?
The latest analyst rating for Evolus (NASDAQ: EOLS) was provided by Needham, and Evolus reiterated their buy rating.
When was the last upgrade for Evolus (EOLS)?
The last upgrade for Evolus Inc happened on January 29, 2024 when Barclays raised their price target to $16. Barclays previously had an equal-weight for Evolus Inc.
When was the last downgrade for Evolus (EOLS)?
There is no last downgrade for Evolus.
When is the next analyst rating going to be posted or updated for Evolus (EOLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolus was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Evolus (EOLS) correct?
While ratings are subjective and will change, the latest Evolus (EOLS) rating was a reiterated with a price target of $0.00 to $22.00. The current price Evolus (EOLS) is trading at is $11.54, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.